Healthcare - Biotechnology - NASDAQ - DE
$ 2.54
-4.87 %
$ 570 M
Market Cap
-1.97
P/E
INCOME STATEMENT
53.8 M
REVENUE
-274 M
OPERATING INCOME
-260 M
NET INCOME
EFFICIENCY
Earnings Waterfall
CureVac N.V.
| Revenue | 53.8 M |
| Cost Of Revenue | 124 M |
| Gross Profit | -70.6 M |
| Operating Expenses | 212 M |
| Operating Income | -274 M |
| Other Expenses | -14.2 M |
| Net Income | -260 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 53.8 | 67.4 | 103.0 | 48.9 | 17.4 | 12.9 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 124.4 | 184.0 | 238.2 | 14.2 | 28.0 | 17.7 |
| Gross Profit | (70.6) | (116.6) | (135.2) | 34.7 | (10.6) | (4.9) |
| OPERATING INCOME | ||||||
| Operating Expenses | 211.8 | 134.3 | 277.1 | 158.7 | 88.9 | 68.0 |
| Selling, General and Administrative Expenses | 76.4 | 89.4 | 88.9 | 45.8 | 43.9 | 21.5 |
| Research and Development Expenses | 115.7 | 62.5 | 815.9 | 113.8 | 43.2 | 41.7 |
| Operating Income | (274.2) | (249.5) | (412.3) | (124.0) | (99.5) | (72.8) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 2.5 | 3.7 | 10.3 | 22.1 | 1.5 | 0.3 |
| Total Other Income | 14.2 | 0.3 | (0.2) | (20.0) | (0.6) | 1.7 |
| Pre-Tax Income | (260.0) | (249.2) | (412.5) | (129.8) | (100.1) | (71.1) |
| NET INCOME | ||||||
| Tax Provision | 0.2 | (0.1) | (0.8) | (0.7) | (0.3) | 0.1 |
| Net Income | (260.2) | (249.0) | (411.7) | (129.1) | (99.9) | (71.2) |
| EPS | 1.18 | 1.32 | 2.21 | 0.98 | 0.53 | 0.4 |